Science and Research Content

News Archive

LWW selects CCC’ Rightslink service for easy ordering of permissions online -

Healthcare publisher Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, US, has teamed up with the Copyright Clearance Center's (CCC) Rightslink system to automate online ordering of copyright permissions. Rightslink claims to be the most widely used web-based licensing application,… Read More

EMC Corporation and John Wiley & Sons partner to produce information storage technology reference -

Storage and management services provider EMC Corporation, US, has announced a partnership with publisher John Wiley & Sons, US, to produce Information Storage and Management: Storing, Managing and Protecting Digital Information. Information Storage and Management (ISM) is projected as the definitive reference… Read More

MedPage Today named best online healthcare publication -

Medical news service MedPage Today, US, has announced that it has been named the Best Overall Web Publication by the American Society of Healthcare Publication Editors (ASHPE) in ASHPE's 2009 annual awards competition. MedPage Today provides 24/7 real-time coverage and continuing medical education credit to physicians… Read More

Nigel Wilson resigns as Deputy Chief Executive and Chief Financial Officer of UBM -

Niche information services provider United Business Media Limited, UK, has announced that Nigel Wilson has tendered his resignation as Deputy Chief Executive and Chief Financial Officer. Also, he has stepped down as a member of UBM's Board. The move follows his decision to join Legal and… Read More

Latest edition of Blogspeak now online -

The eighth edition of blogspeak is now online. Featured are Janet D. Stemwedel (When big pharma pays a publisher to publish a fake journal...); Ben Parr (Is Real-time the Future of the Web?); Stevan Harnad (The Freedom to Publish and the protection of Copyright); and Colin Smith (Open Access and… Read More

Elsevier admits error in promoting Merck drug -

STM publisher Elsevier, Netherlands, has issued a public statement over its role in the marketing of the Vioxx anti-arthritis drug. The publisher acknowledged that it had failed to meet its disclosure standards in producing a publication sponsored by US pharmaceutical group Merck. In a statement issued… Read More


sponsor links

For banner ads click here